These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 19805479

  • 1. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta.
    Ehrenborg E, Krook A.
    Pharmacol Rev; 2009 Sep; 61(3):373-93. PubMed ID: 19805479
    [Abstract] [Full Text] [Related]

  • 2. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S, Lopez-Soriano J, Holst D, Gaudel C, Jehl-Pietri C, Fredenrich A, Grimaldi PA.
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular disease and PPARdelta: targeting the risk factors.
    Muscat GE, Dressel U.
    Curr Opin Investig Drugs; 2005 Sep; 6(9):887-94. PubMed ID: 16187688
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD, Wagner N.
    Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
    Kannisto K, Chibalin A, Glinghammar B, Zierath JR, Hamsten A, Ehrenborg E.
    Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
    [Abstract] [Full Text] [Related]

  • 6. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?
    Grimaldi PA.
    Biochimie; 2005 Jan; 87(1):5-8. PubMed ID: 15733729
    [Abstract] [Full Text] [Related]

  • 7. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
    Smith AG, Muscat GE.
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome.
    Takahashi S, Tanaka T, Kodama T, Sakai J.
    Pharmacol Res; 2006 Jun; 53(6):501-7. PubMed ID: 16713711
    [Abstract] [Full Text] [Related]

  • 9. Lipids, lipoproteins, and peroxisome proliferator activated receptor-delta.
    Sprecher DL.
    Am J Cardiol; 2007 Dec 03; 100(11 A):n20-4. PubMed ID: 18047848
    [Abstract] [Full Text] [Related]

  • 10. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.
    Risérus U, Sprecher D, Johnson T, Olson E, Hirschberg S, Liu A, Fang Z, Hegde P, Richards D, Sarov-Blat L, Strum JC, Basu S, Cheeseman J, Fielding BA, Humphreys SM, Danoff T, Moore NR, Murgatroyd P, O'Rahilly S, Sutton P, Willson T, Hassall D, Frayn KN, Karpe F.
    Diabetes; 2008 Feb 03; 57(2):332-9. PubMed ID: 18024853
    [Abstract] [Full Text] [Related]

  • 11. Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
    Jucker BM, Yang D, Casey WM, Olzinski AR, Williams C, Lenhard SC, Legos JJ, Hawk CT, Sarkar SK, Newsholme SJ.
    Am J Physiol Endocrinol Metab; 2007 Nov 03; 293(5):E1256-64. PubMed ID: 17726146
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N, Duez H, Fruchart JC, Staels B.
    Circ Res; 2004 May 14; 94(9):1168-78. PubMed ID: 15142970
    [Abstract] [Full Text] [Related]

  • 13. PPAR delta agonists and metabolic diseases.
    Kang K, Hatano B, Lee CH.
    Curr Atheroscler Rep; 2007 Jan 14; 9(1):72-7. PubMed ID: 17169250
    [Abstract] [Full Text] [Related]

  • 14. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W, De Keyzer D, Pelat M, Verhamme P, Ganame J, Bielicki JK, Mertens A, Quarck R, Benhabilès N, Marguerie G, Mackness B, Mackness M, Ninio E, Herregods MC, Balligand JL, Holvoet P.
    Circulation; 2004 Nov 16; 110(20):3259-69. PubMed ID: 15533870
    [Abstract] [Full Text] [Related]

  • 15. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
    Fuster G, Busquets S, Ametller E, Olivan M, Almendro V, de Oliveira CC, Figueras M, López-Soriano FJ, Argilés JM.
    Cancer Res; 2007 Jul 01; 67(13):6512-9. PubMed ID: 17616713
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta.
    Kim HJ, Ham SA, Kim SU, Hwang JY, Kim JH, Chang KC, Yabe-Nishimura C, Kim JH, Seo HG.
    Circ Res; 2008 Feb 01; 102(2):193-200. PubMed ID: 18007025
    [Abstract] [Full Text] [Related]

  • 17. PPAR agonists: multimodal drugs for the treatment of type-2 diabetes.
    Gross B, Staels B.
    Best Pract Res Clin Endocrinol Metab; 2007 Dec 01; 21(4):687-710. PubMed ID: 18054742
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
    Chen W, Wang LL, Liu HY, Long L, Li S.
    Basic Clin Pharmacol Toxicol; 2008 Sep 01; 103(3):240-6. PubMed ID: 18684227
    [Abstract] [Full Text] [Related]

  • 19. Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms.
    McGee SL, Hargreaves M.
    Clin Exp Pharmacol Physiol; 2006 Apr 01; 33(4):395-9. PubMed ID: 16620308
    [Abstract] [Full Text] [Related]

  • 20. PPARbeta/delta ligands as modulators of the inflammatory response.
    Kilgore KS, Billin AN.
    Curr Opin Investig Drugs; 2008 May 01; 9(5):463-9. PubMed ID: 18465655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.